Anti-ZIKV Neutralizing Antibody (V3S-0723-FY196) (CAT#: V3S-0723-FY196)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description Clone m302 binds ZIKV-DIII with a measured KD of 47 nM. m302 mAb did not show binding to influenza HA protein. m302 showed synergistic neutralization of ZIKV in vitro and in a mouse model of ZIKV infection.
Clonality Monoclonal
Host Species Human
Target Species Zika Virus (ZIKV)
Immunogen Recombinant ZIKV DIII protein
Affinity 47 nM
Isotype IgG

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; WB; Neut

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target ZIKV
Alternative Name Zika virus; ZIKV
Research Area Microbiology
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry